Raymond James & Associates’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
SCM
RCM
PCM
Raymond James & Associates's BCAT Position: Q3 2024 in Review
Raymond James & Associates increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 18% in Q3 2024, buying an estimated $336K and bringing the position to 135,956 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2153.
Raymond James & Associates first reported a position in BCAT in Q4 2020 and has held it in 16 quarters since. The position peaked at $16.4M in Q2 2023. 80 funds tracked by Wall St. Rank hold BCAT as of Q3 2024.
- Raymond James & Associates held 135,956 shares of BlackRock Capital Allocation Term Trust worth $2.24M as of Q3 2024.
- Raymond James & Associates bought 20,513 BlackRock Capital Allocation Term Trust shares in Q3 2024, an estimated $336K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2153 holding.
- Raymond James & Associates first reported a position in BlackRock Capital Allocation Term Trust in Q4 2020 and has held it in 16 quarters since.
- Raymond James & Associates's BlackRock Capital Allocation Term Trust position peaked at $16.4M in Q2 2023.
- 80 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.